Yonezawa A - Search Results

1

Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics.

Yonezawa A, Inui K. Yonezawa A, et al. Br J Pharmacol. 2011 Dec;164(7):1817-25. doi: 10.1111/j.1476-5381.2011.01394.x. Br J Pharmacol. 2011. PMID: 21457222 Free PMC article. Review.

2

Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons.

Takada Y, Yonezawa A, Kume T, Katsuki H, Kaneko S, Sugimoto H, Akaike A. Takada Y, et al. Among authors: yonezawa a. J Pharmacol Exp Ther. 2003 Aug;306(2):772-7. doi: 10.1124/jpet.103.050104. Epub 2003 May 6. J Pharmacol Exp Ther. 2003. PMID: 12734391

3

Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat.

Yonezawa A, Masuda S, Nishihara K, Yano I, Katsura T, Inui K. Yonezawa A, et al. Biochem Pharmacol. 2005 Dec 5;70(12):1823-31. doi: 10.1016/j.bcp.2005.09.020. Epub 2005 Oct 20. Biochem Pharmacol. 2005. PMID: 16242669

4

Up-regulation of nicotinic acetylcholine receptors by central-type acetylcholinesterase inhibitors in rat cortical neurons.

Kume T, Sugimoto M, Takada Y, Yamaguchi T, Yonezawa A, Katsuki H, Sugimoto H, Akaike A. Kume T, et al. Among authors: yonezawa a. Eur J Pharmacol. 2005 Dec 19;527(1-3):77-85. doi: 10.1016/j.ejphar.2005.10.028. Epub 2005 Nov 28. Eur J Pharmacol. 2005. PMID: 16313899

5

Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2.

Masuda S, Terada T, Yonezawa A, Tanihara Y, Kishimoto K, Katsura T, Ogawa O, Inui K. Masuda S, et al. Among authors: yonezawa a. J Am Soc Nephrol. 2006 Aug;17(8):2127-35. doi: 10.1681/ASN.2006030205. Epub 2006 Jun 28. J Am Soc Nephrol. 2006. PMID: 16807400 Free article.

6

Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family).

Yonezawa A, Masuda S, Yokoo S, Katsura T, Inui K. Yonezawa A, et al. J Pharmacol Exp Ther. 2006 Nov;319(2):879-86. doi: 10.1124/jpet.106.110346. Epub 2006 Aug 16. J Pharmacol Exp Ther. 2006. PMID: 16914559

7

Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity.

Yokoo S, Yonezawa A, Masuda S, Fukatsu A, Katsura T, Inui K. Yokoo S, et al. Among authors: yonezawa a. Biochem Pharmacol. 2007 Aug 1;74(3):477-87. doi: 10.1016/j.bcp.2007.03.004. Epub 2007 Mar 12. Biochem Pharmacol. 2007. PMID: 17582384

8

Identification and functional characterization of a novel human and rat riboflavin transporter, RFT1.

Yonezawa A, Masuda S, Katsura T, Inui K. Yonezawa A, et al. Am J Physiol Cell Physiol. 2008 Sep;295(3):C632-41. doi: 10.1152/ajpcell.00019.2008. Epub 2008 Jul 16. Am J Physiol Cell Physiol. 2008. PMID: 18632736 Free article.

9

Transcellular transport of organic cations in double-transfected MDCK cells expressing human organic cation transporters hOCT1/hMATE1 and hOCT2/hMATE1.

Sato T, Masuda S, Yonezawa A, Tanihara Y, Katsura T, Inui K. Sato T, et al. Among authors: yonezawa a. Biochem Pharmacol. 2008 Oct 1;76(7):894-903. doi: 10.1016/j.bcp.2008.07.005. Epub 2008 Jul 12. Biochem Pharmacol. 2008. PMID: 18674516

10

Significance of organic cation transporter 3 (SLC22A3) expression for the cytotoxic effect of oxaliplatin in colorectal cancer.

Yokoo S, Masuda S, Yonezawa A, Terada T, Katsura T, Inui K. Yokoo S, et al. Among authors: yonezawa a. Drug Metab Dispos. 2008 Nov;36(11):2299-306. doi: 10.1124/dmd.108.023168. Epub 2008 Aug 18. Drug Metab Dispos. 2008. PMID: 18710896

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results